EIC Accelerator: European Funding for Game-Changing Innovation
- Type
- funding
- Deadline
- 2 Sep 2026
The European Innovation Council's Accelerator backs single startups, SMEs, and small mid-caps carrying a "game changing" innovation from Technology Readiness Level 6 toward market, blending a grant of under EUR 2.5 million with an equity investment of EUR 1 to 10 million under what the EIC calls a patient capital principle. Open to applicants from EU Member States and Horizon Europe-associated countries, against rolling cut-off dates through the year. Seen through the Symbiotic Design Framework, that grant-plus-equity structure is a working case of Mutualism: capital and market access for the innovator, mission-oriented return for the funder.
The EIC Accelerator is the European Innovation Council's flagship instrument for single startups, SMEs, and small mid-caps (up to 499 employees) developing an innovation the EIC itself describes as game changing, one with real potential to create or disrupt a market. It backs companies already at Technology Readiness Levels 6 to 8, past early validation and heading toward scale, blending a grant of under EUR 2.5 million with an equity investment of EUR 1 to 10 million under what the programme calls a patient capital principle. Mid-caps can apply for the equity component only. Applicants from EU Member States and Horizon Europe-associated countries submit against rolling cut-off dates through the year, closing at 5pm Brussels time; the next open cut-off after today falls on 2 September 2026. The 2026 budget runs to roughly EUR 220 million for the thematic Challenges track and EUR 414 million for the open, bottom-up track.
Seen through the Symbiotic Design Framework, an instrument like this is a live case of Mutualism, the framework's term for a relationship in which every participant walks away with a net benefit: the innovator gains capital, validation, and market access, while the funding body advances the strategic opportunities its own thematic Challenges are built to surface, an approach the framework traces to Mariana Mazzucato's account of mission-oriented innovation, public funding organized around a mission rather than a gap to fill. Symbiosis, the framework's central logic, treats that pairing of public patient capital and private innovation as the relationship worth examining, not just the technology sitting on either side of it.
More information
Opportunities